New treatments for eczema and atopic dermatitis may be on the way
On 14 December, the US Food and Drug Administration approved the first non-steroidal therapy for eczema in more than 15 years. The drug, an ointment called Eucrisa (crisaborole), inhibits a protein called phosphodiesterase-4 and was developed by Anacor Pharmaceuticals of Palo Alto, California (a company recently acquired by Pfizer). It targets an anti-inflammatory mechanism already […]
